Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Choosing Wisely in hemato-medical oncology

Dr Omar Abdihamid - Garissa Cancer Centre, Garissa, Kenya
Choosing Wisely in hemato-medical oncology ( Dr Omar Abdihamid - Garissa Cancer Centre, Garissa, Kenya )
28 Mar 2023

SOFT study: Clinical relevance of genomic alterations in premenopausal HR+, HER2- early breast cancer

Prof Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia
SOFT study: Clinical relevance of genomic alterations in premenopausal HR+, HER2- early breast cancer ( Prof Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia )
28 Mar 2023

Precision oncology: Present and future in breast cancer

Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy
Precision oncology: Present and future in breast cancer ( Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy )
28 Mar 2023

CG0070 plus pembro shows promising efficacy in NMIBC unresponsive to BCG

Dr Roger Li - Moffitt Cancer Center, Tampa, USA
CG0070 plus pembro shows promising efficacy in NMIBC unresponsive to BCG ( Dr Roger Li - Moffitt Cancer Center, Tampa, USA )
22 Mar 2023

Advancing breast cancer diagnosis in the developing world

Dr Hans Junkermann, Prof Dr Erkin Arıbal and Dr Richard Rainsbury
Advancing breast cancer diagnosis in the developing world ( Dr Hans Junkermann, Prof Dr Erkin Arıbal and Dr Richard Rainsbury )
21 Mar 2023

Choosing wisely in multiple myeloma

Dr Bishesh Poudyal - Civil Service Hospital, Kathmandu, Nepal
Choosing wisely in multiple myeloma ( Dr Bishesh Poudyal - Civil Service Hospital, Kathmandu, Nepal )
20 Mar 2023

Upfront [177Lu]Lu-PSMA-617 radioligand therapy prior to radical prostatectomy in men with HR PC

Dr Renu Eapen - Peter MacCallum Cancer Centre, Melbourne, Australia
Upfront [177Lu]Lu-PSMA-617 radioligand therapy prior to radical prostatectomy in men with HR PC ( Dr Renu Eapen - Peter MacCallum Cancer Centre, Melbourne, Australia )
16 Mar 2023

Complete biochemical response below 0.1 ng/ml predicts long-term therapy-free survival via PSMA-radioguided surgery

Prof Tobias Maurer - Martini-Klinik Prostate Cancer Center, Hamburg, Germany
Complete biochemical response below 0.1 ng/ml predicts long-term therapy-free survival via PSMA-radioguided surgery ( Prof Tobias Maurer - Martini-Klinik Prostate Cancer Center, Hamburg, Germany )
16 Mar 2023

Diagnostic performance of 18F-rhPSMA-7.3 PET in newly diagnosed unfavourable intermediate to very high-risk prostate cancer

Prof Tobias Maurer - Martini-Klinik Prostate Cancer Center, Hamburg, Germany
Diagnostic performance of 18F-rhPSMA-7.3 PET in newly diagnosed unfavourable intermediate to very high-risk prostate cancer ( Prof Tobias Maurer - Martini-Klinik Prostate Cancer Center, Hamburg, Germany )
16 Mar 2023

Pembro monotherapy for participants with BCG–unresponsive HR NMIBC shows anti-tumour activity

Prof Andrea Necchi - The Vita-Salute San Raffaele University, Milan, Italy
Pembro monotherapy for participants with BCG–unresponsive HR NMIBC shows anti-tumour activity ( Prof Andrea Necchi - The Vita-Salute San Raffaele University, Milan, Italy )
16 Mar 2023

Digital rectal examination is not useful as a solitary screening tool for prostate cancer in young men

Prof Peter Albers - Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany
Digital rectal examination is not useful as a solitary screening tool for prostate cancer in young men ( Prof Peter Albers - Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany )
16 Mar 2023

Single intensive screening intervention using PSA and Stockholm3 in combination might reduce prostate cancer mortality

Prof Peter Albers - Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany
Single intensive screening intervention using PSA and Stockholm3 in combination might reduce prostate cancer mortality ( Prof Peter Albers - Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany )
16 Mar 2023